Back to 
Woodline Partners LP
Woodline Partners LP
NGEN1 quarters
Position history for Woodline Partners LP's holdings in NERVGEN PHARMA CORP
Woodline Partners LP holds 250,500 shares of NGEN (NERVGEN PHARMA CORP), worth $516,030 as of 2026-Q2. This is a new position. NGEN represents 0.0% of Woodline Partners LP's portfolio.
Current Value
$516,030
Current Shares
250,500
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/